Hologic Deal to Acquire Gen-Probe Passes US Antitrust Review | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic today said that its $3.7 billion deal to acquire Gen-Probe has cleared US antitrust review.

The Bedford, Mass.-based firm said that the initial 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 had expired without a request for additional information from the US Federal Trade Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.